COVID-19 / Coronavirus
CU Medicine study published in The Lancet Infectious Diseases concludes that a novel oral microencapsulated live bacteria consortia (SIM01) alleviates long COVID symptoms
2023-12-08 10:38
1773
HONG KONG, Dec. 8, 2023 /PRNewswire/ -- A randomised, double-blind, placebo-controlled trial (RECOVERY STUDY) conducted by TheChinese University of Hong Kong (CUHK)'s Faculty of Medicine (CU Medicine) and Microbiota I-Center (MagIC) showed that an oral microbiome microencapsulated formula (SIM01)...
Herbalife Introduces Array of New Wellness Products Tailored to Needs of Consumers in Asia Pacific
2023-12-07 15:00
2619
HONG KONG, Dec. 7, 2023 /PRNewswire/ -- Herbalife, a global health and wellness company, today announced that during the year to date it has launched 20 unique products (43 product SKUs) inAsia Pacific markets, including formulations specially tailored to the needs of local consumers. The l...
The Grand Opening of HKSH's Proton Therapy Centre Marks a Significant Advancement in Precision Cancer Treatment in Hong Kong
2023-12-02 19:22
2347
HONG KONG, Dec. 2, 2023 /PRNewswire/ -- HKSH Medical Group (HKSH) announced today the grand opening of the HKSH Proton Therapy Centre (the Centre) – the first of its kind inHong Kong. Located at the HKSH Eastern Medical Centre in A Kung Ngam,Shau Kei Wan, the Centre boasts two state-of-the-art tr...
AI reality vs. myth: Twelve predictions from SAS for 2024
2023-11-30 21:34
1812
AI will not take all jobs nor end civilization. But it will help businesses make better decisions. CARY, N.C., Nov. 30, 2023 /PRNewswire/ -- Artificial intelligence (AI) is everywhere. And stories are rampant about its promise and its threat. Will AI's potential be realized in the year ahead? SA...
GILEAD SCIENCES AWARDS OVER US$1.5 MILLION TO STRENGTHEN SUPPORT FOR COMMUNITY-LED HIV PROJECTS IN ASIA PACIFIC
2023-11-29 11:00
1597
–2023 Gilead Asia Pacific Rainbow Grant Funding Will Support 40 Projects In 2024-2025 To Reduce HIV Stigma And Improve Equity Across Asia Pacific – – Since 2018, The Gilead Asia Pacific Rainbow Grant Has Awarded Close To US$6 Million To 144 Community-Based Projects In The Region, Supporting 130 00...
JOGO HEALTH (INDIA) GRANTED WORLD'S FIRST JOINT COMMISSION INTERNATIONAL(JCI) ACCREDITATION FOR A DIGITAL CLINIC
2023-11-28 16:01
1283
* Chicago based Joint Commission helps healthcare organizations improve clinical and operational processes and build staff competencies and knowledge of leading practices. * More than 22,000 US health care organizations are accredited by Joint Commission and a majority of US state government...
Jebhealth Partners Airwallex Singapore and Visa to Launch Corporate Health and Employee Benefits Payment Cards
2023-11-27 09:00
1786
SINGAPORE, Nov. 27, 2023 /PRNewswire/ -- Health Technology (HealthTech) is a nascent industry and is associated with digital software products to address inefficiencies and reduce cost in the delivery of health services to the community. Jebhealth, a Singapore-based Health Technology (HealthTech...
DxVx, plans to make a license-in agreement of OVM-200 and conduct clinical trials in Asia
2023-11-24 22:00
3023
- Final stage in licensing OVM-200 from Oxford Vacmedix in the UK - DxVx plans to proceed its own clinical trials in Asia, including Korea and China SEOUL, South Korea, Nov. 24, 2023 /PRNewswire/ -- DxVx announces today that it will conduct its own clinical trials of OVM-200, an anti-cancer vacc...
Global Assistance and Healthcare Expands in Southeast Asia
2023-11-22 10:30
2490
JAKARTA, Indonesia, Nov. 22, 2023 /PRNewswire/ -- In a post pandemic and inflationary era, corporations are marked by dual pressures of regional market expansion and cost containment, Global Assistance and Healthcare (GAH), a leading provider of global medical emergency assistance services, is s...
Prenetics Announces Third Quarter 2023 Financial Results
2023-11-20 19:30
1911
HONG KONG, Nov. 20, 2023 /PRNewswire/ -- Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a leading genomics-driven health sciences company, today announced financial results for the third quarter endedSeptember 30, 2023, along with recent business updates. Third Quarter 20...
epitoMAP Inc., Animal Allergy Clinical Laboratories Inc. and Nippon Zenyaku Kogyo Co., Ltd. Enter into License Agreement
2023-11-17 16:00
1139
SAGAMIHARA, Japan, Nov. 17, 2023 /PRNewswire/ -- epitoMAP Inc. (hereinafter "epitoMAP") and Animal Allergy Clinical Laboratories Inc. (hereinafter "AACL") entered into a License Agreement for an antibody pharmaceutical for veterinary use, CRE-DR-B, with Nippon Zenyaku Kogyo Co., Ltd. (hereinafter...
"Read Medicine Labels" - How to Safely Use Green Chiretta Against COVID-19
2023-11-15 14:58
1580
Chula
Noble Capital Markets Initiates Coverage on YS Biopharma With Outperform Rating and US$5.25 Price Target
2023-11-14 21:30
1152
GAITHERSBURG, Md., Nov. 14, 2023 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious disea...
Geekplus projects win in three categories in the 2023 Supply Chain Excellence Awards
2023-11-14 21:06
1180
* Geekplus, beside partners Asda Logistics, AMH Material Handling and Dr. Max Romania, has been recognized as the best project in three different ACEA award categories: The Unipart Logistics Digital Transformation Award, The Healthcare & Pharmaceutical Supply Chain Excellence Award, and the Vi...
Brinc Hosts Successful Asia Health Innovation Summit 2023, Fostering Greater Ideations and Collaborations in the Healthcare Sector
2023-11-10 18:43
2093
HONG KONG, Nov. 10, 2023 /PRNewswire/ -- The Asia Health Innovation Summit 2023
Felzartamab Granted Breakthrough Therapy Designation by U.S. Food and Drug Administration (FDA) for Primary Membranous Nephropathy (PMN)
2023-11-02 20:00
862
* FDA granted Breakthrough Therapy Designation for felzartamab in PMN upon positive clinical data from M-PLACE, a Phase 2 study led by I-Mab partner HI-Bio * I-Mab has full development and commercialization rights of felzartamab in Greater China for all indications, with Phase 3 multiple myelom...
I-Mab Announces Poster Presentations of 4-1BB Bispecific Antibody Portfolio at SITC 2023
2023-11-01 20:00
1190
ROCKVILLE, MD, U.S. and SHANGHAI, China, Nov. 1, 2023 /PRNewswire/ -- I-Mab (Nasdaq: IMAB) (the "Company"), a global biotechnology company focused on bringing highly differentiated medicines to patients around the world through the discovery, development, and commercialization of novel immunother...
YS Biopharma Announces Completion of Subject Enrollment in Pivotal Phase 3 Clinical Trial of PIKA Rabies Vaccine
2023-10-31 20:30
1213
GAITHERSBURG, Md., Oct. 31, 2023 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious disea...
Singapore PM Office awards Public Service Medal to Muhammed Aziz Khan
2023-10-27 17:36
1605
SINGAPORE, Oct. 27, 2023 /PRNewswire/ -- Chairman of Summit Group, Muhammed Aziz Khan, received the Public Service Medal (COVID-19) at the National Awards for his outstanding contribution to society during the pandemic. On behalf of the Prime Minister's Office ofSingapore, Minister for Health, Mr...
YS Biopharma Announces Receipt of Nasdaq Notice
2023-10-26 20:30
3107
GAITHERSBURG, Md., Oct. 26, 2023 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious disea...
Week's Top Stories
Most Reposted
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions
[Picked up by 294 media titles]
2024-04-22 16:00Trina Solar and PetroGreen Partner to Accelerate Philippine Solar Adoption with 117MW Supply Agreement
[Picked up by 291 media titles]
2024-04-22 06:00China's Yiwu Establishes Welcoming Committee to Attract International Buyers
[Picked up by 286 media titles]
2024-04-19 13:25Revenue Surpasses 50 Billion: BlueFocus Accelerates Towards the AI Native Era
[Picked up by 275 media titles]
2024-04-23 15:43INTAMSYS Becomes 3D Printing Equipment Supplier for the WORLDSKILLS LYON 2024 COMPETITION
[Picked up by 272 media titles]
2024-04-24 17:09Most Read
China's Yiwu Establishes Welcoming Committee to Attract International Buyers
2024-04-19 13:25
7757